back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-01-18 07:11 Tx date 2025-01-17 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
1,085,404 | |
| Filed 2024-07-18 07:10 Tx date 2024-07-15 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
3,010,714 | |
| Filed 2023-09-13 10:08 Tx date 2022-01-17 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-197,618 vol |
0 | |
| Filed 2023-09-13 10:05 Tx date 2023-09-11 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$6,250
+62,500 vol $0.10 each |
62,500 | |
| Filed 2023-09-13 09:59 Tx date 2023-09-11 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+125,000 vol $0.08 each |
985,404 | |
| Filed 2023-06-28 22:17 Tx date 2023-06-23 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,150,000 vol |
2,760,714 | |
| Filed 2022-02-04 10:53 Tx date 2022-02-04 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,250
+100,000 vol $0.1225 each |
860,404 | |
| Filed 2021-07-26 08:56 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,610,714 vol |
1,610,714 | |
| Filed 2021-07-26 08:52 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-24 07:15 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
+1,610,714 vol |
||
| Filed 2021-07-22 16:47 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
+1,610,714 vol |
||
| Filed 2021-07-22 16:47 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
+1,610,714 vol |
1,610,714 | |
| Filed 2021-07-22 16:37 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-1,150,000 vol |
0 | |
| Filed 2021-05-22 13:51 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$18,000
+100,000 vol $0.18 each |
760,404 | |
| Filed 2021-05-22 12:58 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-1,928.70
-10,715 vol $0.18 each |
197,618 | |
| Filed 2021-05-22 12:57 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-16,071.30
-89,285 vol $0.18 each |
208,333 | |
| Filed 2021-05-22 12:49 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$10,000,000,000
+100,000 vol $100,000 each |
760,404 | |
| Filed 2021-05-22 12:49 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$10,000,000,000
+100,000 vol $100,000 each |
||
| Filed 2021-05-22 12:42 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-1,928.52
-10,714 vol $0.18 each |
||
| Filed 2021-05-22 12:41 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-16,071.48
-89,286 vol $0.18 each |
||
| Filed 2020-12-09 14:34 Tx date 2020-12-07 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,100
+115,000 vol $0.14 each |
660,404 | |
| Filed 2020-09-29 12:24 Tx date 2020-08-19 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+150,000 vol $0.16 each |
1,150,000 | |
| Filed 2020-06-28 19:39 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
208,333 | ||
| Filed 2020-06-28 19:00 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-20 10:50 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-07 19:46 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-07 15:32 Tx date 2020-02-28 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$72,000
+400,000 vol $0.18 each |
1,000,000 | |
| Filed 2019-12-27 14:56 Tx date 2019-12-19 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+89,285 vol |
297,618 | |
| Filed 2019-12-27 14:49 Tx date 2019-12-19 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$24,999
+178,571 vol $0.14 each |
545,404 | |
| Filed 2018-11-20 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-20 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
208,333 | ||
| Filed 2018-10-26 Tx date 2018-10-23 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,000
+100,000 vol $0.10 each |
600,000 | |
| Filed 2018-10-22 Tx date 2018-10-22 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,972
+76,500 vol $0.065 each |
366,833 | |
| Filed 2018-06-08 Tx date 2018-06-06 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$720.00
+12,000 vol $0.06 each |
270,333 | |
| Filed 2018-06-08 Tx date 2018-06-08 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+20,000 vol $0.06 each |
290,333 | |
| Filed 2018-06-01 Tx date 2018-06-01 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+100,000 vol $0.20 each |
500,000 | |
| Filed 2018-06-01 Tx date 2018-05-17 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+100,000 vol $0.20 each |
||
| Filed 2018-05-30 Tx date 2018-05-17 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+100,000 vol $0.20 each |
500,000 | |
| Filed 2018-01-16 Tx date 2018-01-15 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+50,000 vol $0.09 each |
258,333 | |
| Filed 2017-11-17 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-11-17 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-11-17 Tx date 2017-11-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$120,000
+400,000 vol $0.30 each |
400,000 | |
| Filed 2017-09-07 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
208,333 | ||
| Filed 2017-09-07 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
208,333 |